These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17348492)

  • 21. Genetic risk factors associated with lipid-lowering drug-induced myopathies.
    Vladutiu GD; Simmons Z; Isackson PJ; Tarnopolsky M; Peltier WL; Barboi AC; Sripathi N; Wortmann RL; Phillips PS
    Muscle Nerve; 2006 Aug; 34(2):153-62. PubMed ID: 16671104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Necrotizing myopathies].
    Kumamoto T
    Ryoikibetsu Shokogun Shirizu; 2001; (36):239-42. PubMed ID: 11596379
    [No Abstract]   [Full Text] [Related]  

  • 23. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract]   [Full Text] [Related]  

  • 24. Side effects of statins--prevalence, relevance, consequences.
    Sinzinger H
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318
    [No Abstract]   [Full Text] [Related]  

  • 25. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipid lowering, statins and cancer.
    Wierzbicki AS
    Int J Clin Pract; 2006 Sep; 60(9):1022-4. PubMed ID: 16939539
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk assessment and hyperlipidemia.
    Becker J
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):277-85. PubMed ID: 18644510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increased CK in lipid-lowering therapy].
    Assmann G
    Internist (Berl); 1997 Nov; 38(11):1114. PubMed ID: 9453967
    [No Abstract]   [Full Text] [Related]  

  • 30. Complications and side effects. Concerns about statins.
    TreatmentUpdate; 2005; 17(4):5-6. PubMed ID: 17228472
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonprescription statins: not ready for prime time.
    Whayne TF
    Am J Cardiol; 2008 Mar; 101(5):745-6; author reply 746. PubMed ID: 18308034
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipid metabolism diseases].
    Schwandt P
    Med Monatsschr Pharm; 2003 Nov; 26(11):368-72; quiz 373-4. PubMed ID: 14652921
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
    Marsà Carretero M; Alos Manrique C; Valles Callol JA
    Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
    [No Abstract]   [Full Text] [Related]  

  • 34. Ezetimibe and statin-associated myopathy.
    Phillips PS
    Ann Intern Med; 2004 Oct; 141(8):649. PubMed ID: 15492351
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 37. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myopathy associated with statin therapy.
    Wahl D; Petitpain N; Frederic M; Bour S; Kaminsky P; Trechot P
    Neuromuscul Disord; 2007 Aug; 17(8):661-2. PubMed ID: 17537633
    [No Abstract]   [Full Text] [Related]  

  • 39. Ezetimibe and statin-associated myopathy.
    Fux R; Mörike K; Gundel UF; Hartmann R; Gleiter CH
    Ann Intern Med; 2004 Apr; 140(8):671-2. PubMed ID: 15096354
    [No Abstract]   [Full Text] [Related]  

  • 40. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.